Post-Botox Rehabilitation and Serial Casting in Paediatric Spasticity
In short
Botulinum toxin provides a temporary therapeutic window of spasticity reduction that must be coupled with serial casting and physiotherapy for lasting mobility.
In this guide (6 sections)
Intramuscular injection of Botulinum Toxin Type A (BoNT-A) is an established focal medical intervention used to manage localized spasticity in children with cerebral palsy. By selectively cleaving SNAP-25 proteins within presynaptic cholinergic nerve terminals, botulinum toxin temporarily blocks acetylcholine release at the neuromuscular junction, inducing focal, reversible muscle paresis and significantly reducing spastic muscle tone. However, botulinum toxin alone does not stretch contracted collagen, lengthen shortened tendons, or teach functional motor coordination. To achieve lasting clinical gains, BoNT-A injection must be viewed as opening a temporary three-to-four-month therapeutic window. Combining botulinum toxin with immediate, structured paediatric physiotherapy and serial casting provides the definitive intervention needed to remodel muscular architecture and improve functional gait.
Domestic and Cultural Indian Realities
In India, botulinum toxin injections represent a substantial out-of-pocket medical expense for families, as vials are rarely fully covered by government or private insurance schemes. Often, families make great financial sacrifices to afford the injections under the mistaken belief that the medicine alone will permanently resolve the child walking difficulty. When spasticity begins to return several months later because post-injection physiotherapy and serial casting were neglected, parents experience profound despair and disillusionment. Paediatric physiotherapists must counsel families beforehand that botulinum toxin is merely a facilitator: without intensive post-injection physiotherapy, daily stretching, and rigid nighttime bracing, up to 90 percent of potential motor benefits are lost.
Clinical Biomechanics and Neurological Development
In spastic cerebral palsy, chronic high motor tone keeps muscles in a permanently shortened position. Over months and years, this dynamic spasticity reshapes into fixed myotendinous contracture: longitudinal muscle growth fails to keep pace with bony skeletal elongation, sarcomeres are lost in series, and the endomysium undergoes extensive fibrotic collagen cross-linking. When BoNT-A reduces dynamic tone, the underlying structural muscle shortening remains. Applying serial fibreglass casts two to four weeks post-injection, when muscle flaccidity peaks, delivers a continuous, low-load mechanical stretch to the relaxed muscle belly. This prolonged stretch activates mechanotransduction pathways that stimulate sarcomerogenesis (the biological addition of new sarcomeres in series), restoring true physiological muscle length.
Clinical Assessment and Developmental Staging
Objective baseline evaluation is conducted prior to injection and repeated at 4, 12, and 24 weeks post-injection. The Modified Tardieu Scale measures the angle of catch at fast velocity (R1) and total passive range at slow velocity (R2); the difference (R2 minus R1) quantifies the dynamic spastic component treatable by BoNT-A. Functional mobility is evaluated using the Edinburgh Visual Gait Score (EVGS), observational 2D video gait analysis, and the 6-Minute Walk Test (6MWT). Candidates for post-botox serial casting must show significant dynamic equinus or hamstring tightness with preserved passive joint range.
Targeted Rehabilitation and Mobility Exercises
The clinical protocol initiates serial casting approximately two to three weeks following BoNT-A injections. Lightweight, well-padded below-knee synthetic fibreglass casts are applied with the subtalar joint held in neutral and the ankle positioned at end-range comfortable dorsiflexion. Casts are worn continuously for 5 to 7 days, then removed, skin inspected, joint range remeasured, and a new cast applied at a newly acquired dorsiflexion angle. This sequence is repeated for 2 to 4 cycles until maximal dorsiflexion (ideally 10 to 15 degrees) is achieved. Once casting is complete, intensive strengthening of the lengthened muscle antagonistic pair (e.g., anterior tibialis) is initiated alongside custom AFO fitting.
Post-Casting Active-Resisted Dorsiflexion and Heel-Walking Training
Objective: Strengthen antagonistic anterior tibialis and retrain active heel strike after calf lengthening
- 1Seat the child comfortably on a bench with heels resting flat on the floor.
- 2Place a light resistance band over the forefoot, anchoring the other end under your foot.
- 3Instruct the child to pull their toes and forefoot up toward their shin against the band resistance.
- 4Hold the maximum dorsiflexion contraction for 3 seconds, then slowly lower the foot back down.
- 5Progress immediately to standing: have the child take 10 deliberate steps walking forward on their heels across a padded mat.
| Rehabilitation Stage | Timing Post-Injection | Clinical Physiotherapy Actions and Goals |
|---|---|---|
| Acute Post-Injection | Days 1 to 14 | Maintain active physiotherapy; avoid intense stretching until toxin binds; monitor for local soreness |
| Serial Casting Phase | Weeks 2 to 5 (2-3 weeks duration) | Apply weekly below-knee casts at new end-range; encourage full weight-bearing walking inside casts |
| Post-Cast Muscle Retraining | Weeks 6 to 16 | Fit new rigid or hinged AFOs immediately; aggressive strengthening of antagonist muscles and gait retraining |
| Maintenance Phase | Weeks 16 to 24+ | Night-time splinting adherence, functional home exercise programme, and objective re-evaluation |
Red Flags and Immediate Specialist Escalation
During serial casting, immediate emergency cast removal is mandatory if the child exhibits signs of neurovascular compromise: cold, pale, or cyanotic toes, loss of capillary refill, unrelenting crying, or severe burning pain over the heel indicating pressure ulcer formation. Systemically, while rare, any symptoms of generalized botulinum toxin spread (dysphagia, difficulty swallowing, generalized flaccid weakness, or respiratory distress) require emergency hospital admission for supportive medical care.
Frequently Asked Questions
Can a child walk while wearing serial casts after botulinum toxin?
Yes. In fact, children are strongly encouraged to bear full weight and walk in their serial casts using cast shoes. Active weight-bearing walking drives ground forces through the lengthened muscle; this improves structural sarcomere adaptation.
How long do the spasticity-reducing effects of botulinum toxin last?
The pharmacological reduction in muscle tone typically lasts between 3 and 4 months, after which nerve terminals sprout new synaptic connections. The true structural muscle lengthening gained through post-botox serial casting and physiotherapy, however, can be maintained long-term with consistent night splints.
Related recovery guides & articles
BookPhysio.in Editorial Team
The BookPhysio.in editorial team writes and maintains this content, checking it against reliable clinical sources. Content follows our medical review policy: general information only, and no page claims a clinical review until a named registered physiotherapist has signed it off.
Read our medical review policy